These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6357766)

  • 1. Impairment of glucose tolerance in yellow (Avy/A) (BALB/c X VY) F-1 hybrid mice by hyperglycemic peptide(s) from human pituitary glands.
    Frigeri LG; Wolff GL; Robel G
    Endocrinology; 1983 Dec; 113(6):2097-105. PubMed ID: 6357766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hypophysectomy and the insulin-like and anti-insulin pituitary peptides on carbohydrate metabolism in yellow Avy/A (BALB/c x VY)F1 hybrid mice.
    Salem MA; Lewis UJ; Haro LS; Kishi K; McAllister DL; Seavey BK; Bee G; Wolff GL
    Proc Soc Exp Biol Med; 1989 Sep; 191(4):408-19. PubMed ID: 2672006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of response to insulin and anti-insulin action by two human pituitary peptides in lean agouti A/a, obese yellow Avy/A, and C57BL/6J-ob/ob mice.
    Salem MA; Wolff GL
    Proc Soc Exp Biol Med; 1989 Jun; 191(2):113-23. PubMed ID: 2657747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential responses of yellow Avy/A and agouti A/a (BALB/c X VY) F1 hybrid mice to the same diets: glucose tolerance, weight gain, and adipocyte cellularity.
    Frigeri LG; Wolff GL; Teguh C
    Int J Obes; 1988; 12(4):305-20. PubMed ID: 3058616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased sensitivity of adipose tissue to insulin after in vivo treatment of yellow Avy/A obese mice with amino-terminal peptides of human growth hormone.
    Frigeri LG; Teguh C; Ling N; Wolff GL; Lewis UJ
    Endocrinology; 1988 Jun; 122(6):2940-5. PubMed ID: 3131129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetogenic response to streptozotocin varies among obese yellow and among lean agouti (BALB/c x VY)F1 hybrid mice.
    Wolff GL; Greenman DL; Frigeri LG; Morrissey RL; Suber RL; Felton RP
    Proc Soc Exp Biol Med; 1990 Feb; 193(2):155-63. PubMed ID: 2137249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
    Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
    Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caloric restriction abolishes enhanced metabolic efficiency induced by ectopic agouti protein in yellow mice.
    Wolff GL; Kodell RL; Kaput JA; Visek WJ
    Proc Soc Exp Biol Med; 1999 Jun; 221(2):99-104. PubMed ID: 10352119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplified response to phenobarbital promotion of hepatotumorigenesis in obese yellow Avy/A (C3H x VY) F-1 hybrid mice.
    Wolff GL; Morrissey RL; Chen JJ
    Carcinogenesis; 1986 Nov; 7(11):1895-8. PubMed ID: 3769139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains.
    Alberts P; Nilsson C; Selen G; Engblom LO; Edling NH; Norling S; Klingström G; Larsson C; Forsgren M; Ashkzari M; Nilsson CE; Fiedler M; Bergqvist E; Ohman B; Björkstrand E; Abrahmsen LB
    Endocrinology; 2003 Nov; 144(11):4755-62. PubMed ID: 12960099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of age and obesity on the metabolism of lindane by black a/a, yellow Avy/a, and pseudoagouti Avy/a phenotypes of (YS x VY) F1 hybrid mice.
    Chadwick RW; Copeland MF; Wolff GL; Cooke N; Whitehouse DA; Mole ML
    J Toxicol Environ Health; 1985; 16(6):771-96. PubMed ID: 2419580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic glutathione S-transferase activity in mice: effects of Avy/-genotype, obesity, lindane treatment, and sex.
    Wolff GL; Suber RL
    Proc Soc Exp Biol Med; 1986 Apr; 181(4):535-41. PubMed ID: 2419915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The actions of dichloroacetic acid on blood glucose, liver glycogen and fatty acid synthesis in obese-hyperglycaemic (ob/ob) and lean mice.
    Enser M; Whittington FM
    Horm Metab Res; 1983 May; 15(5):225-9. PubMed ID: 6347856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of novel beta-adrenoceptor agonists on carbohydrate metabolism: relevance for the treatment of non-insulin-dependent diabetes.
    Cawthorne MA; Carroll MJ; Levy AL; Lister CA; Sennitt MV; Smith SA; Young P
    Int J Obes; 1984; 8 Suppl 1():93-102. PubMed ID: 6152558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated appearance of chemically induced mammary carcinomas in obese yellow (Avy/A) (BALB/c X VY) F1 hybrid mice.
    Wolff GL; Kodell RL; Cameron AM; Medina D
    J Toxicol Environ Health; 1982 Jul; 10(1):131-42. PubMed ID: 6290678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response effects of ectopic agouti protein on iron overload and age-associated aspects of the Avy/a obese mouse phenome.
    Wolff GL; Whittaker P
    Peptides; 2005 Oct; 26(10):1697-711. PubMed ID: 15982784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumorigenic responses to lindane in mice: potentiation by a dominant mutation.
    Wolff GL; Roberts DW; Morrissey RL; Greenman DL; Allen RR; Campbell WL; Bergman H; Nesnow S; Frith CH
    Carcinogenesis; 1987 Dec; 8(12):1889-97. PubMed ID: 2445499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of dehydroepiandrosterone (DHEA) and its metabolites in obese-hyperglycemic mutant mice.
    Coleman DL
    Prog Clin Biol Res; 1988; 265():161-75. PubMed ID: 2970093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma free tryptophan, brain serotonin, and an endocrine profile of the genetically obese hyperglycemic mouse at 4--5 months of age.
    Garthwaite TL; Kalkhoff RK; Guansing AR; Hagen TC; Menahan LA
    Endocrinology; 1979 Nov; 105(5):1178-82. PubMed ID: 226347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raw vegetable food containing high cyclo (his-pro) improved insulin sensitivity and body weight control.
    Song MK; Rosenthal MJ; Song AM; Yang H; Ao Y; Yamaguchi DT
    Metabolism; 2005 Nov; 54(11):1480-9. PubMed ID: 16253637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.